IXICO PLC

IXI

Company Profile

  • Business description

    IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

  • Contact

    15 Long Lane
    4th Floor, Griffin Court
    LondonEC1A 9PN
    GBR

    T: +44 2037637499

    E: [email protected]

    https://www.ixico.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 September 2026

    Employees

    79

Stocks News & Analysis

stocks

Chart of the Week: Has gold reached bear market territory?

Investors are facing a shifting landscape.
stocks

ASX share benefiting from favourable industry trends

We anticipate further earnings growth.
stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,885.6059.900.68%
CAC 407,974.82157.882.02%
DAX 4023,287.09607.052.68%
Dow JONES (US)46,691.871,475.733.26%
FTSE 10010,345.53169.081.66%
HKSE25,294.03505.892.04%
NASDAQ21,847.181,052.545.06%
Nikkei 22553,739.682,675.965.24%
NZX 50 Index12,825.8786.24-0.67%
S&P 5006,581.0052.480.80%
S&P/ASX 2008,671.8053.100.62%
SSE Composite Index3,948.5556.691.46%

Market Movers